Borman, Phil J <br/><br/>
Development, validation and transfer into a factory environment of a liquid chromatography tandem mass spectrometry assay for the highly neurotoxic impurity FMTP (4-(4-fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine) in paroxetine active pharmaceutical ingredient (API).  [electronic resource] 

 -  Journal of pharmaceutical and biomedical analysis  Dec 2008 
 - 1082-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0731-7085 
<br/><br/><label>Standard No.: </label>10.1016/j.jpba.2008.08.026  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antidepressive Agents, Second-Generation--analysis<br/>Chemistry, Pharmaceutical--methods<br/>Chromatography, Liquid--methods<br/>Drug Contamination<br/>Drug Industry--methods<br/>Molecular Structure<br/>Neurotoxicity Syndromes--etiology<br/>Paroxetine--chemistry<br/>Pharmaceutical Preparations--analysis<br/>Pyridines--chemistry<br/>Reference Standards<br/>Reproducibility of Results<br/>Sensitivity and Specificity<br/>Tandem Mass Spectrometry--methods